Tradewind BioScience is building tools to attack highly aggressive and deadly human cancers. Tradewind BioScience (Tradewind) is a biotech company that is building novel therapeutic antibodies to attack cancer stem cells, with an initial focus on ovarian cancer.
Tradewind BioScience
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://tradewindbio.com
Founded2016
Disease Focus
Development Stage
STOCK CODENon Listed
Address38 Morningside Dr Daly City, CA, 94015-4509Dr Daly CityUnited States
38 Morningside Dr Daly City, CA, 94015-4509
Dr Daly City
United States
Contact Number+1 415-317-4818
+1 415-317-4818
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]
Tradewind is developing a panel of antibody-based therapeutic candidates, both monovalent and bi-specific, targeting novel secreted proteins involved in maintaince of tumorigenesis.
In Jan 2018, Tradewind Biosciences received $120k in a seed round funding from Y Combinator.